The modern medicine increasingly relies on the concepts of personalization and selectivity to increase the precision of diagnoses and the effectiveness of therapies, while keeping at minimum the invasivity. When declined at the nano-scale, those concepts are translated into the development of molecular sensors for pathogens, nucleic acids or molecular markers, design and building of (intra)cellular detecting and delivery systems, and development of cell-type selective therapeutic strategies. We operate in all these fields, with a wide range of different approaches.
- Development of Functionalized Nano-Materials for Biosensors Applications
- Mn2+ mediated detection of RNA and DNA through surface hybridization with PNA
- Identification of targeting molecules and formulation of nanostructures for treatment of different types of diseases
- Biofunctionalised metal nanoparticles for therapeutic and diagnostic applications
- A New therapeutic strategy to fight SARS-CoV-2 infection
- Deep Learning and Optical Tweezers to study Intrinsically Disordered Proteins of Therapeutic Value
- Nanoscaffolds for regenerative medicine and cellular monitoring
- Intracellular condensates
- Nanoscaffolds for neuroscience
- Nanotechnologies for point-of-care diagnostics and nanomedicine
- A multidisciplinary approach to FLASH radiotherapy